ERBB3 and cancer: The expression of the proliferation-associated marker Ki-67 at a higher frequency in ErbB3-positive NSCLC cases than in ErbB3-negative tumors was suggestive of a contribution of ErbB3 to an aggressive cancer behaviour [41].